arrow
P

Phillip G. Febbo

Veracyte
H指数:50
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prevalence of Potential Candidates for Targeted Therapies According to Treatment-related Transcriptomic Signatures Among 140 548 Patients with Nonmetastatic Prostate Cancer

根据治疗相关转录组特征,在140 548例非转移性前列腺癌患者中靶向治疗潜在候选者的患病率

2025-05-100
PRE
Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases

提交给公共数据库的液体活检数据的最低技术数据元素

2020-02-0423
OAAI
A 17-Gene Genomic Prostate Score Assay Provides Independent Information on Adverse Pathology in the Setting of Combined Multiparametric Magnetic Resonance Imaging Fusion Targeted and Systematic Prostate Biopsy
2018-09-0131
OAAI
A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease

基于活检的17基因基因组前列腺评分作为临床局部疾病手术治疗男性转移和前列腺癌死亡的预测指标

2018-01-0189
PREAI
Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium
2017-04-1233
OAAI
A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer
2015-07-01249
OAAI